SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-19-001373
Filing Date
2019-11-22
Accepted
2019-11-22 07:31:08
Documents
1
Period of Report
2019-11-20

Document Format Files

Seq Description Document Type Size
1 form4-11222019_071155.html 4  
1 form4-11222019_071155.xml 4 56072
  Complete submission text file 0001415889-19-001373.txt   57376
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Biller Jonathan (Reporting) CIK: 0001744749 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34912 | Film No.: 191238704